Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Sam Lai, PhD Associate Professor- Director, Pharmacoengineering Program at UNC Eshelman School of Pharmacy - University of North Carolina at Chapel Hill


Lai is an Associate Professor and Director of Pharmacoengineering at the UNC Eshelman School of Pharmacy overseeing a dynamic group working at the interface of engineering, immunology and drug delivery. Previously, he helped pioneer the development of mucus-penetrating particles, a breakthrough that formed the basis of Kala Pharmaceuticals, which has since completed multiple successful Phase III clinical trials, filed NDA in early 2018, and went IPO in 2017. His research has spun out a number of startups the past few years, including Mucommune, Inhalon Biopharma, and AI Tracking Solutions.

Agenda Sessions